Although PD-L1 positive is suggestive for therapeutic efficacy, it is still worth noticing that the expression levels of PD-L1 are incorrectly measured sometimes due to tumor heterogeneity, dynamic changes of PD-L1, lack of validated biomarkers, and inaccurate biopsy sampling 8, 59. Here, CD274 is linked to neoplasm.